Finding the right tests…
Emergency services available 24 x 7
Emergency services available 24 x 7
Finding the right tests…
ELISA
HSV 2 IgM Antibodies checks for the earliest antibody your immune system raises against herpes simplex virus type 2, the type most often behind genital herpes. It can turn positive before the longer-lasting IgG antibody does, which is why some doctors reach for it when a very recent genital HSV-2 exposure is suspected. Major bodies including the CDC do not recommend IgM testing for herpes as a routine tool, because it is not specific to HSV-2 over HSV-1 and can also turn positive during a repeat outbreak, not just a new infection. Discuss with your doctor whether a swab of an active sore would give a more direct answer.
This test measures IgM antibody against HSV using an ELISA-based method, reported as reactive, non-reactive, or equivocal. Because it is not type-specific and can also turn positive during a recurrent outbreak or cross-react with related viruses, doctors read a reactive result together with symptoms, timing, and, if a sore is present, a direct swab test, rather than as a stand-alone answer.
IgM against HSV-2 can appear in the blood before IgG does, which sounds like an ideal way to catch a brand-new genital herpes infection early. In practice, it falls short of that promise. It doesn't reliably separate HSV-2 from HSV-1, and it can turn positive again during a recurrent genital outbreak in someone who has had HSV-2 for years, not only at first infection. It can also cross-react with other herpesviruses, such as chickenpox or CMV, which further blurs a positive reading.
For these reasons, the CDC states that IgM testing for HSV is not useful for telling a first infection from a recurrence and does not recommend it as a standard part of herpes diagnosis. It still gets ordered occasionally when a doctor is chasing a specific, recent-exposure question and wants an antibody-based data point alongside the clinical picture, since most people carrying HSV-2 have no recognized symptoms at all and may only be tested because a partner was diagnosed.
If you currently have a genital sore, a direct swab test on that sore is generally the more dependable way to confirm HSV-2 as the cause, rather than a blood antibody result. Ask your doctor which approach fits your situation.
No. The CDC states that IgM testing for herpes is not useful for telling a first infection from a recurrence and does not recommend it as standard practice, since it isn't type-specific and can cross-react with related viruses.
In specific situations, such as a suspected first-time genital HSV-2 exposure with a matching illness, a doctor may want an antibody-based data point alongside your symptoms and history.
Yes, and that is a key reason it isn't considered reliable enough to separate a first infection from a repeat one.
A direct swab test on the sore is generally more dependable for confirming HSV-2 as the cause. Ask your doctor which test fits your situation.
This page is general information about the test, not medical advice. Your own report's reference ranges apply — please discuss your results with your doctor.
Testing is usually reserved for a specific reason, such as a partner's diagnosis or a suspected recent exposure, rather than as blanket screening, given how many people carry HSV-2 without ever noticing symptoms.
IgG reflects past exposure and lasts for life, while IgM is meant to flag something more recent, though its limited specificity means your doctor will weigh it carefully.
Yes, it can cross-react with related viruses in the herpes family, such as chickenpox virus or CMV, which is part of why it isn't used as a routine screening tool.